Epidemiological Study of Mammary Tumors in Female Dogs Diagnosed during the Period 2002-2012: A Growing Animal Health Problem

Epidemiological studies enable us to analyze disease behavior, define risk factors and establish fundamental prognostic criteria, with the purpose of studying different types of diseases. The aim of this study was to determine the epidemiological characteristics of canine mammary tumors diagnosed during the period 2002-2012. The study was based on a retrospective study consisting of 1,917 biopsies of intact dogs that presented mammary gland lesions. Biopsies were sent to the Department of Pathology FMVZ-UNAM diagnostic service. The annual incidence of mammary tumors was 16.8%: 47.7% (benign) and 47.5% (malignant). The highest number of cases was epithelial, followed by mixed tumors. The most commonly diagnosed tumors were tubular adenoma, papillary adenoma, tubular carcinoma, papillary carcinoma, solid carcinoma, complex carcinoma and carcinosarcoma. Pure breeds accounted for 80% of submissions, and the Poodle, Cocker Spaniel and German Shepherd were consistently affected. Adult female dogs (9 to 12 years old) were most frequently involved, followed by 5- to 8-year-old females. Some association between breeds with histological types of malignant tumors was observed, but no association was found between breeds and BN. Mammary tumors in intact dogs had a high incidence. Benign and malignant tumors had similar frequencies, with an increase in malignant tumors in the past four years of the study. Epithelial tumors were more common, and the most affected were old adult females, purebreds and small-sized dogs. Mammary tumors in dogs are an important animal health problem that needs to be solved by improving veterinary oncology services in Mexico.

[1]  J. Donohue,et al.  Primary nonphylloides breast sarcomas. , 2003, American journal of surgery.

[2]  Agneta Egenvall,et al.  Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002. , 2005, Preventive veterinary medicine.

[3]  N. Rocha,et al.  Malignant mammary tumor in female dogs: environmental contaminants , 2010, Diagnostic pathology.

[4]  Jiri Bartek,et al.  An Oncogene-Induced DNA Damage Model for Cancer Development , 2008, Science.

[5]  Richard P. Hill,et al.  Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability , 2008, Nature Reviews Cancer.

[6]  C. R. Daleck,et al.  Neoplasias mamárias em cadelas: influência hormonal e efeitos da ovario-histerectomia como terapia adjuvante , 2000 .

[7]  J. Reif,et al.  Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital. , 1974, Cancer research.

[8]  V. Zappulli,et al.  Classification and Grading of Canine Mammary Tumors , 2011, Veterinary pathology.

[9]  K. Lindblad-Toh,et al.  Mammary tumor development in dogs is associated with BRCA1 and BRCA2. , 2009, Cancer research.

[10]  R. Klopfleisch,et al.  Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles , 2010, BMC Cancer.

[11]  P. Walsh,et al.  Clinical and experimental studies of benign prostatic hyperplasia. , 1990, The Urologic clinics of North America.

[12]  A. Gürel,et al.  Evaluation of clinical and pathological characteristics of 155 canines with mammary tumours: a retrospective study , 2009 .

[13]  F. Yu 17Beta-estradiol epoxidation as the molecular basis for breast cancer initiation and prevention. , 2002, Asia Pacific journal of clinical nutrition.

[14]  D. Taylor,et al.  Factors influencing canine mammary cancer development and postsurgical survival. , 1969, Journal of the National Cancer Institute.

[15]  N. Sood,et al.  Epidemiological Studies on Canine Mammary Tumour and its Relevance for Breast Cancer Studies , 2012 .

[16]  M. Katdare,et al.  Estradiol metabolism: an endocrine biomarker for modulation of human mammary carcinogenesis. , 1997, Environmental health perspectives.

[17]  G. Castellani,et al.  Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry , 2010, BMC veterinary research.

[18]  N. Toft,et al.  Data from the Danish Veterinary Cancer Registry on the occurrence and distribution of neoplasms in dogs in Denmark , 2010, Veterinary Record.

[19]  L. Moe Population-based incidence of mammary tumours in some dog breeds. , 2001, Journal of reproduction and fertility. Supplement.

[20]  E. García-Zepeda,et al.  Estrogen receptor beta and CXCR4/CXCL12 expression: differences by sex and hormonal status in lung adenocarcinoma. , 2014, Archives of medical research.